Jennison Associates’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-27,262
Closed -$868K 708
2021
Q1
$868K Sell
27,262
-5,405
-17% -$131K ﹤0.01% 640
2020
Q4
$747K Buy
32,667
+4,772
+17% +$110K ﹤0.01% 603
2020
Q3
$703K Buy
+27,895
New +$762K ﹤0.01% 582
2019
Q4
Sell
-56,622
Closed -$722K 653
2019
Q3
$722K Buy
+56,622
New +$815K ﹤0.01% 579
2017
Q4
Sell
-175,225
Closed -$3.24M 678
2017
Q3
$3.24M Sell
175,225
-14,745
-8% -$255K ﹤0.01% 515
2017
Q2
$3.33M Buy
189,970
+1,062
+0.6% +$20.3K ﹤0.01% 521
2017
Q1
$3.51M Hold
188,908
﹤0.01% 520
2016
Q4
$3.86M Sell
188,908
-6,203
-3% -$156K ﹤0.01% 523
2016
Q3
$5.84M Sell
195,111
-1,051
-0.5% -$31.3K 0.01% 503
2016
Q2
$5.29M Sell
196,162
-273
-0.1% -$6.16K 0.01% 497
2016
Q1
$3.68M Sell
196,435
-70,973
-27% -$1.35M ﹤0.01% 503
2015
Q4
$8.28M Buy
267,408
+909
+0.3% +$27.6K 0.01% 490
2015
Q3
$5.71M Buy
266,499
+176,443
+196% +$5.53M 0.01% 535
2015
Q2
$3.42M Buy
90,056
+904
+1% +$29.7K ﹤0.01% 572
2015
Q1
$2.8M Buy
89,152
+286
+0.3% +$9.69K ﹤0.01% 569
2014
Q4
$3.12M Sell
88,866
-98
-0.1% -$2.44K ﹤0.01% 547
2014
Q3
$1.86M Buy
88,964
+133
+0.1% +$2.75K ﹤0.01% 591
2014
Q2
$1.93M Sell
88,831
-10,109
-10% -$213K ﹤0.01% 575
2014
Q1
$2.75M Buy
98,940
+334
+0.3% +$11.8K ﹤0.01% 562
2013
Q4
$2.71M Buy
+98,606
New +$2.58M ﹤0.01% 547

Other funds holding MGNX

Jennison Associates's MGNX Position: Q2 2021 in Review

Jennison Associates sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 27,262 shares — an estimated $868K sold.

Jennison Associates first reported a position in MGNX in Q4 2013 and held it in 20 quarters. The position peaked at $8.28M in Q4 2015. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

  • Jennison Associates reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
  • Jennison Associates sold 27,262 MacroGenics shares in Q2 2021, an estimated $868K.
  • Jennison Associates first reported a position in MacroGenics in Q4 2013 and held it in 20 quarters.
  • Jennison Associates's MacroGenics position peaked at $8.28M in Q4 2015.
  • 149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on Jennison Associates's 13F filing for Q2 2021, filed 12 Aug 2021.